Established in 2021, this GMP manufacturer is a leading CTD dossier owner and manufacturer, supplying high-quality pharmaceutical products across multiple countries and regions worldwide. Specializing in cytotoxic products, it operates advanced production lines for liquid injections, lyophilized injections, tablets, and capsules. As a CTD dossier owner and manufacturer, it adheres to strict regulatory standards, holding GMP approvals from WHO cGMP, ISO 9001:2015, and authorities in the Philippines, Cambodia, Kenya, Sri Lanka, and Syria. This GMP manufacturer, as a CTD dossier owner and manufacturer, ensures excellence in pharmaceutical development.